References
- Vardiman JW, Thiele J, Arber DA et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114(5), 937–951 (2009).
- Scala E, Russo G, Cadoni S et al. Skewed expression of activation, differentiation and homing-related antigens in circulating cells from patients with cutaneous T cell lymphoma associated with CD7- T helper lymphocytes expansion. J. Invest. Dermatol. 113(4), 622–627 (1999).
- Harmon CB, Witzig TE, Katzmann JA, Pittelkow MR. Detection of circulating T cells with CD4+CD7- immunophenotype in patients with benign and malignant lymphoproliferative dermatoses. J. Am. Acad. Dermatol. 35(3 Pt 1), 404–410 (1996).
- Kukel S, Reinhold U, Oltermann I, Kreysel HW. Progressive increase of CD7- T cells in human blood lymphocytes with ageing. Clin. Exp. Immunol. 98(1), 163–168 (1994).
- Ohnuma K, Dang NH, Morimoto C. Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function. Trends Immunol. 29(6), 295–301 (2008).
- Narducci MG, Scala E, Bresin A et al. Skin homing of Sézary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26/dipeptidylpeptidase IV. Blood 107(3), 1108–1115 (2006).
- Kniep B, Kniep E, Ozkucur N et al. 9-O-acetyl GD3 protects tumor cells from apoptosis. Int. J. Cancer 119(1), 67–73 (2006).
- Wada T, Seki H, Konno A et al. Developmental changes and functional properties of human memory T cell subpopulations defined by CD60 expression. Cell. Immunol. 187(2), 117–123 (1998).
- Gocht A, Gadatsch A, Rutter G, Kniep B. CDw60: an antigen expressed in many normal tissues and in some tumours. Histochem. J. 32(7), 447–456 (2000).
- Picchio MC, Scala E, Pomponi D et al. CXCL13 is highly produced by Sézary cells and enhances their migratory ability via a synergistic mechanism involving CCL19 and CCL21 chemokines. Cancer Res. 68(17), 7137–7146 (2008).
- Campbell JJ, Clark RA, Watanabe R, Kupper TS. Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors. Blood 116(5), 767–771 (2010).
- Cossarizza A, Barbieri D, Londei M. T cell repertoire usage in humans, from newborns to centenarians. Int. Rev. Immunol. 12(1), 41–55 (1995).
- Scala E, Narducci MG, Amerio P et al. T cell receptor-Vβ analysis identifies a dominant CD60+ CD26- CD49d- T cell clone in the peripheral blood of Sézary syndrome patients. J. Invest. Dermatol. 119(1), 193–196 (2002).
- Langerak AW, van Den Beemd R, Wolvers-Tettero IL et al. Molecular and flow cytometric analysis of the Vβ repertoire for clonality assessment in mature TCRαβ T-cell proliferations. Blood 98(1), 165–173 (2001).
- Vonderheid EC, Boselli CM, Conroy M et al. Evidence for restricted Vβ usage in the leukemic phase of cutaneous T cell lymphoma. J. Invest. Dermatol. 124(3), 651–661 (2005).
- Scala E, Abeni D, Pomponi D et al. Predictive role of 9-O-acetylated ganglioside D3 (CD60) and α4β1 (CD49d) expression in the survival of patients with Sezary Syndrome. Haematologica 95(11),1905–1912 (2010).
- Mehrany K, El-Azhary RA, Bouwhuis SA, Pittelkow MR. Cutaneous T-cell lymphoma and atopy: is there an association? Br. J. Dermatol. 149(5), 1013–1017 (2003).
- Kotzin BL, Leung DY, Kappler J, Marrack P. Superantigens and their potential role in human disease. Adv. Immunol. 54, 99–166 (1993).
- Kim KS, Jacob N, Stohl W. In vitro and in vivo T cell oligoclonality following chronic stimulation with staphylococcal superantigens. Clin. Immunol. 108(3), 182–189 (2003).
- Abeni D, Frontani M, Sampogna F et al. Circulating CD8+ lymphocytes, white blood cells, and survival in patients with mycosis fungoides. Br. J. Dermatol. 153(2), 324–330 (2005).
- Scala E, Abeni D, Palazzo P et al. Specific IgE toward allergenic molecules is a new prognostic marker in patients with Sézary syndrome. Int. Arch. Allergy Immunol. 157(2), 159–167 (2012).
- Wang H, Diepgen TL. Atopic dermatitis and cancer risk. Br. J. Dermatol. 154(2), 205–210 (2006).